Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHA:600613)
China
· Delayed Price · Currency is CNY 6.43
+0.03 (0.47%)
Mar 10, 2026, 3:00 PM CST
SHA:600613 Revenue
Shanghai Shenqi Pharmaceutical Investment Management had revenue of 437.01M CNY in the quarter ending September 30, 2025, a decrease of -3.51%. This brings the company's revenue in the last twelve months to 1.88B, down -14.14% year-over-year. In the year 2024, Shanghai Shenqi Pharmaceutical Investment Management had annual revenue of 2.05B, down -12.48%.
Revenue (ttm)
1.88B
Revenue Growth
-14.14%
P/S Ratio
1.73
Revenue / Employee
1.49M
Employees
1,266
Market Cap
3.26B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.05B | -292.14M | -12.48% |
| Dec 31, 2023 | 2.34B | -47.67M | -2.00% |
| Dec 31, 2022 | 2.39B | 85.58M | 3.72% |
| Dec 31, 2021 | 2.30B | 484.03M | 26.61% |
| Dec 31, 2020 | 1.82B | -108.59M | -5.63% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang Zhenyuan Share | 2.67B |
| Zhejiang Haisen Pharmaceutical | 510.33M |
| Guangdong Jiaying Pharmaceutical | 410.00M |
| Hubei Guangji Pharmaceutical | 605.87M |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 251.56M |
| Shandong Keyuan Pharmaceutical | 435.52M |
| Hangzhou Bio-Sincerity Pharma-Tech | 590.33M |
| Hangzhou Minsheng Healthcare | 744.06M |